PATH
Menu

A pilot clinical study suggests that E6 is an appropriate biomarker for diagnosis of cervical pre-cancer and cancer in a novel oncoprotein-based rapid diagnostic assay for cervical pre-cancer and cancer. Presented at: International Papillomavirus Conference 2009, May 8, 2009; Malmo, Sweden.

Author(s): Schweizer J, Berard-Bergery M, Bisht A, et al

Corporate author(s): PATH, Arbor Vita Corporation, Johns Hopkins Bloomberg School of Public Health

Publication date: May 2009

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Health technologiesDiagnostic technologies

Reproductive healthSexually transmitted infections

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA